These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7521825)

  • 1. The role of metabolic activation in drug toxicity.
    Hinson JA; Pumford NR; Nelson SD
    Drug Metab Rev; 1994; 26(1-2):395-412. PubMed ID: 7521825
    [No Abstract]   [Full Text] [Related]  

  • 2. [Physiological and toxicological aspects of metabolic activation of drugs].
    Szukalski B
    Acta Physiol Pol; 1984; 35 Suppl 27():36-81. PubMed ID: 6100809
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the biotransformation of drugs and its significance in pharmaceutical industry].
    Hansen T
    Nord Med; 1967 Nov; 78(47):1549-54. PubMed ID: 6075279
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.
    Kumar S; Kassahun K; Tschirret-Guth RA; Mitra K; Baillie TA
    Curr Opin Drug Discov Devel; 2008 Jan; 11(1):43-52. PubMed ID: 18175266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent binding of electrophilic metabolites to macromolecules.
    Pohl LR; Branchflower RV
    Methods Enzymol; 1981; 77():43-50. PubMed ID: 6173572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Toxicity caused by so-called reactive metabolites of drugs].
    Pessayre D; Mazel P; Benhamou JP
    Nouv Presse Med; 1976 May; 5(18):1201-4. PubMed ID: 775438
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of pharmacokinetics in realizing the embryotoxic action of drugs].
    Smol'nikova NM; Boĭko SS; Liubimov BI
    Farmakol Toksikol; 1986; 49(2):106-11. PubMed ID: 3519275
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of toxic pathways of metabolism by deuterium substitution.
    Pohl LR; Gillette JR
    Drug Metab Rev; 1984-1985; 15(7):1335-51. PubMed ID: 6398777
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cultured hepatocytes and drugs].
    Bourel M; Guillouzo A; Ratanasavanh M; Chesne C; Guguen Guillouzo C
    C R Seances Soc Biol Fil; 1990; 184(3-4):211-6. PubMed ID: 2151313
    [No Abstract]   [Full Text] [Related]  

  • 10. Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.
    Masubuchi N; Makino C; Murayama N
    Chem Res Toxicol; 2007 Mar; 20(3):455-64. PubMed ID: 17309281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The biochemistry of toxic effects].
    Jacyszyn K
    Folia Med Cracov; 1987; 28(1-2):47-60. PubMed ID: 3623325
    [No Abstract]   [Full Text] [Related]  

  • 12. Detecting and characterizing reactive metabolites by liquid chromatography/tandem mass spectrometry.
    Ma S; Subramanian R
    J Mass Spectrom; 2006 Sep; 41(9):1121-39. PubMed ID: 16967439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocytes--the choice to investigate drug metabolism and toxicity in man: in vitro variability as a reflection of in vivo.
    Gómez-Lechón MJ; Castell JV; Donato MT
    Chem Biol Interact; 2007 May; 168(1):30-50. PubMed ID: 17134688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The biotransformation of drugs in animals and in humans].
    Sanen FJ; Hong E
    Prensa Med Mex; 1969; 34(1):14-8. PubMed ID: 5787500
    [No Abstract]   [Full Text] [Related]  

  • 15. Modern views on pharmacology. II. Drug metabolism.
    Crossland J
    Practitioner; 1971 Feb; 206(232):293-8. PubMed ID: 5554569
    [No Abstract]   [Full Text] [Related]  

  • 16. [Species differences in pharmaco-kinetics of chemicals. Correlations with toxicity (author's transl)].
    Keck G
    Toxicol Eur Res; 1981 Jul; 3(4):207-15. PubMed ID: 7302948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism and pharmacokinetics in children and the elderly.
    Pelkonen O
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):147-8. PubMed ID: 17428146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing the potential for metabolic activation as an integral part of drug design.
    Evans DC; Baillie TA
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):44-50. PubMed ID: 15679171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug interaction].
    Lunde PK; Oye I
    Tidsskr Nor Laegeforen; 1970 Mar; 90(5):493-8. PubMed ID: 4913134
    [No Abstract]   [Full Text] [Related]  

  • 20. Xenobiotic metabolism and toxicity in primary monolayer cultures of hepatocytes.
    Holme JA
    NIPH Ann; 1985 Dec; 8(2):49-63. PubMed ID: 3908998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.